Platelet activation and neutrophil extracellular trap (NET) formation in immune thrombocytopenia: is there an association?

No biological predictors for the increased risk of thrombosis in patients with immune thrombocytopenia (ITP) have been identified. The aim of the study was to investigate platelet and neutrophil activation as well neutrophil extracellular trap (NET) formation in 63 ITP patients and 30 healthy volunt...

Full description

Saved in:
Bibliographic Details
Published inPlatelets (Edinburgh) Vol. 31; no. 7; pp. 906 - 912
Main Authors Lozano, Maria L, Garabet, Lamya, Fernandez-Perez, Maria Piedad, De Los Reyes-García, Ascension M, Diaz-Lozano, Pedro, Garcia-Barbera, Nuria, Aguila, Sonia, Vicente, Vicente, Ghanima, Waleed, Martinez, Constantino, Gonzalez-Conejero, Rocio
Format Journal Article
LanguageEnglish
Published Taylor & Francis 02.10.2020
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:No biological predictors for the increased risk of thrombosis in patients with immune thrombocytopenia (ITP) have been identified. The aim of the study was to investigate platelet and neutrophil activation as well neutrophil extracellular trap (NET) formation in 63 ITP patients and 30 healthy volunteers. Platelet and neutrophil activation was assessed during steady state using flow cytometry analysis, and NETs were evaluated by quantitation of cell free DNA (cfDNA), and citrullinated histone-3-DNA (CitH3-DNA). Patient platelets and neutrophils showed increased CD62 and CD11b expression compared to controls (p = .038, and p = .022, respectively). In patients, platelet activation inversely correlated with platelet count and platelet size (p < .001), and positively correlated with neutrophil degranulation (p = .024). More NET formation, both CitH3-DNA (p = .025) and cfDNA(p < .001), were present in ITP patients compared to controls. CitH3-DNA inversely correlated with CD62 expression on platelets (p = .042), but higher levels of cfDNA were observed in individuals with classical cardiovascular risk factors for thrombosis, and in those with a previous history of thrombotic events. In this disease, the increased platelet activation and plasma NET levels seem to be separable processes that associate (either positively or inversely in the case of CitH3-DNA or platelet degranulation, respectively) to platelet mass.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0953-7104
1369-1635
DOI:10.1080/09537104.2019.1696456